Stocks · Health care · Biological Products, (No Diagnostic Substances)

Denali Therapeutics Inc.

DNLI Clue Score33
United States Fiscal year ends December CIK 0001714899 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Peter Scott Chin
4 Sep 2026
Chief Medical Officer
Sell
1,654
$22.29
$36.87K
Alexander O. Schuth
11 Aug 2026
COFO and Secretary
Sell
2,857
$25.07
$71.62K
Alexander O. Schuth
6 Jan 2026
COFO and Secretary
Sell
17,218
$16.50
$284.10K
Ryan J. Watts
6 Jan 2026
President and CEO
Sell
35,198
$16.50
$580.77K

What was left out

Form 4 filings counted 18
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 0
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 226,552
History held since 8 Dec 2017